Applying insights from biofilm biology to drug development — can a new approach be developed? (original) (raw)

• Murray, C. J. & Lopez, A. D. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349, 1498–1504 (1997).
  Article CAS PubMed Google Scholar
• Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R. & Lappin-Scott, H. M. Microbial biofilms. Annu. Rev. Microbiol. 49, 711–745 (1995).
  Article CAS PubMed Google Scholar
• Potera, C. Studying slime. Environ. Health Perspect. 106, A604–A606 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Martinez, J. L. The role of natural environments in the evolution of resistance traits in pathogenic bacteria. Proc. Biol. Sci. 276, 2521–2530 (2009).
  Article PubMed PubMed Central Google Scholar
• Høiby, N. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta. Pathol. Microbiol. Scand. Suppl. 262, 1–96 (1977).
  Google Scholar
• McCoy, W. F., Bryers, J. D., Robbins, J. & Costerton, J. W. Observations of fouling biofilm formation. Can. J. Microbiol. 27, 910–917 (1981).
  Article CAS PubMed Google Scholar
• Marrie, T. J. & Costerton, J. W. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J. Clin. Microbiol. 19, 687–693 (1984).
  CAS PubMed PubMed Central Google Scholar
• Costerton, J. W. How bacteria stick — a citation classic commentary on how bacteria stick by Costerton, J. W., Geesey, G. G., and Cheng, K. J. Citation classics 48, 18 (1989).
  Google Scholar
• Islam, M. S., Richards, J. P. & Ojha, A. K. Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms. Expert. Rev. Anti. Infect. Ther. 10, 1055–1066 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Muller, F. M., Seidler, M. & Beauvais, A. Aspergillus fumigatus biofilms in the clinical setting. Med. Mycol. 49 (Suppl. 1), 96–100 (2011).
  Article Google Scholar
• Cuellar-Cruz, M., Lopez-Romero, E., Villagomez-Castro, J. C. & Ruiz-Baca, E. Candida species: new insights into biofilm formation. Future. Microbiol. 7, 755–771 (2012).
  Article CAS PubMed Google Scholar
• Donlan, R. M. & Costerton, J. W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167–193 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Parsek, M. R. & Singh, P. K. Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 57, 677–701 (2003).
  Article CAS PubMed Google Scholar
• Hall-Stoodley, L., Costerton, J. W. & Stoodley, P. Bacterial biofilms: from the natural environment to infectious diseases. Nature Rev. Microbiol. 2, 95–108 (2004).
  Article CAS Google Scholar
• Burmolle, M. et al. Biofilms in chronic infections — a matter of opportunity — monospecies biofilms in multispecies infections. FEMS Immunol. Med. Microbiol. 59, 324–336 (2010).
  Article CAS PubMed Google Scholar
• Jensen, P. O., Givskov, M., Bjarnsholt, T. & Moser, C. The immune system versus Pseudomonas aeruginosa biofilms. FEMS Immunol. Med. Microbiol. 59, 292–305 (2010).
  Article CAS PubMed Google Scholar
• Pamp, S. J., Gjermansen, M., Johansen, H. K. & Tolker-Nielsen, T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB–oprM genes. Mol. Microbiol. 68, 223–240 (2008).
  Article CAS PubMed Google Scholar
• Hall-Stoodley, L. et al. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol. Med. Microbiol. 65, 127–145 (2012).
  Article CAS PubMed Google Scholar
• Costerton, J. W., Geesey, G. G. & Cheng, K. J. How bacteria stick. Sci. Am. 238, 86–95 (1978).
  Article CAS PubMed Google Scholar
• Li, H. et al. Antibacterial activity of antibiotic coated silicone grafts. J. Urol. 160, 1910–1913 (1998).
  Article CAS PubMed Google Scholar
• Darouiche, R. O. Treatment of infections associated with surgical implants. N. Engl. J. Med. 350, 1422–1429 (2004).
  Article CAS PubMed Google Scholar
• Safdar, N. & Maki, D. G. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin. Infect. Dis. 43, 474–484 (2006).
  Article PubMed Google Scholar
• Bjarnsholt, T., Tolker-Nielsen, T., Givskov, M., Janssen, M. & Chrsitensen, L. Detection of bacteria by FISH in culture-negative soft tissue filler lesions. Dermatol. Surg. 35, 1620–1624 (2009).
  Article CAS PubMed Google Scholar
• Bjarnsholt, T. et al. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151, 373–383 (2005).
  Article CAS PubMed Google Scholar
• Bjarnsholt, T. et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen. 16, 2–10 (2008).
  Article PubMed Google Scholar
• Bjarnsholt, T. et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44, 547–558 (2009).
  Article PubMed Google Scholar
• Fexby, S. et al. Biological Trojan horse: Antigen 43 provides specific bacterial uptake and survival in human neutrophils. Infect. Immun. 75, 30–34 (2007).
  Article CAS PubMed Google Scholar
• Fux, C. A., Costerton, J. W., Stewart, P. S. & Stoodley, P. Survival strategies of infectious biofilms. Trends Microbiol. 13, 34–40 (2005).
  Article CAS PubMed Google Scholar
• Stewart, P. S. New ways to stop biofilm infections. Lancet 361, 97 (2003).
  Article PubMed Google Scholar
• Stewart, P. S. & Costerton, J. W. Antibiotic resistance of bacteria in biofilms. Lancet 358, 135–138 (2001).
  Article CAS PubMed Google Scholar
• Kim, J., Hahn, J. S., Franklin, M. J., Stewart, P. S. & Yoon, J. Tolerance of dormant and active cells in Pseudomonas aeruginosa PA01 biofilm to antimicrobial agents. J. Antimicrob. Chemother. 63, 129–135 (2009).
  Article CAS PubMed Google Scholar
• Walters, M. C. et al. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47, 317–323 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hentzer, M., Eberl, L. & Givskov, M. Transcriptome analysis of Pseudomonas aeruginosa biofilm development: anaerobic respiration and iron limitation. Biofilms 2, 37–61 (2005).
  Article Google Scholar
• Marvig, R. L. et al. Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 56, 4519–4521 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Imamura, Y. et al. Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. Antimicrob. Agents Chemother. 49, 1377–1380 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Saiman, L. The use of macrolide antibiotics in patients with cystic fibrosis. Curr. Opin. Pulm. Med. 10, 515–523 (2004).
  Article PubMed Google Scholar
• Gillis, R. J. & Iglewski, B. H. Azithromycin retards Pseudomonas aeruginosa biofilm formation. J. Clin. Microbiol. 42, 5842–5845 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ciofu, O., Giwercman, B., Pedersen, S. S. & Høiby, N. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. APMIS 102, 674–680 (1994).
  Article CAS PubMed Google Scholar
• Roveta, S., Marchese, A. & Schito, G. C. Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. Int. J. Antimicrob. Agents 31, 321–328 (2008).
  Article CAS PubMed Google Scholar
• Mascio, C. T., Alder, J. D. & Silverman, J. A. Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob. Agents Chemother. 51, 4255–4260 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• De Rosa, F. G. et al. Early experience with high-dosage daptomycin for prosthetic infections. Clin. Infect. Dis. 49, 1772–1773 (2009).
  Article PubMed Google Scholar
• Hansen, C. R., Pressler, T. & Hoiby, N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J. Cyst. Fibros. 7, 523–530 (2008).
  Article CAS PubMed Google Scholar
• Hurdle, J. G., O'Neill, A. J., Chopra, I. & Lee, R. E. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nature Rev. Microbiol. 9, 62–75 (2011).
  Article CAS Google Scholar
• Palmer, R. J. et al. in Biofilm Infections (eds Bjarnsholt, T., Moser, C., Jensen, P. O. & Høiby, N.) 35–60 (Springer, 2010).
  Google Scholar
• Zimmerli, W. & Trampuz, A. in Biofilm Infections (eds Bjarnsholt, T., Moser, C., Jensen, P. O. & Høiby, N.) 91–110 (Springer, 2010).
  Google Scholar
• Flemming, H. C., Neu, T. R. & Wozniak, D. J. The EPS matrix: the “house of biofilm cells”. J. Bacteriol. 189, 7945–7947 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Madsen, J. S., Burmolle, M., Hansen, L. H. & Sorensen, S. J. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol. Med. Microbiol. 65, 183–195 (2012).
  Article CAS PubMed Google Scholar
• Christensen, B. B. et al. Molecular tools for study of biofilm physiology. Methods Enzymol. 310, 20–42 (1999).
  Article CAS PubMed Google Scholar
• Pamp, S. J., Sternberg, C. & Tolker-Nielsen, T. Insight into the microbial multicellular lifestyle via flow-cell technology and confocal microscopy. Cytometry A 75, 90–103 (2009).
  Article PubMed Google Scholar
• Klausen, M. et al. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol. Microbiol. 48, 1511–1524 (2003).
  Article CAS PubMed Google Scholar
• Klausen, M., aes-Jorgensen, A., Molin, S. & Tolker-Nielsen, T. Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol. Microbiol. 50, 61–68 (2003).
  Article CAS PubMed Google Scholar
• Schleheck, D. et al. Pseudomonas aeruginosa PAO1 preferentially grows as aggregates in liquid batch cultures and disperses upon starvation. PLoS ONE 4, e5513 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Oliver, J. D. Recent findings on the viable but nonculturable state in pathogenic bacteria. FEMS Microbiol. Rev. 34, 415–425 (2010).
  Article CAS PubMed Google Scholar
• Werner, E. et al. Stratified growth in Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 70, 6188–6196 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Folsom, J. P. et al. Physiology of Pseudomonas aeruginosa in biofilms as revealed by transcriptome analysis. BMC Microbiol. 10, 294 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Alhede, M. et al. Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. PLoS ONE 6, e27943 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Worlitzsch, D. et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109, 317–325 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Aanaes, K. et al. Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. J. Cyst. Fibros. 10, 114–120 (2011).
  Article PubMed Google Scholar
• Yang, L. et al. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J. Bacteriol. 190, 2767–2776 (2008).
  Article CAS PubMed Google Scholar
• Lee, B. et al. Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J. Clin. Microbiol. 43, 5247–5255 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, B. et al. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients. Acta. Pathol. Microbiol. Scand. Suppl. 119, 263–274 (2011).
  Article Google Scholar
• Ciofu, O., Mandsberg, L. F., Bjarnsholt, T., Wassermann, T. & Hoiby, N. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology 156, 1108–1119 (2010).
  Article CAS PubMed Google Scholar
• Folkesson, A. et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nature Rev. Microbiol. 10, 841–851 (2012).
  Article CAS Google Scholar
• Moscoso, J. A., Mikkelsen, H., Heeb, S., Williams, P. & Filloux, A. The Pseudomonas aeruginosa sensor RetS switches type III and type VI secretion via c-di-GMP signalling. Environ. Microbiol. 13, 3128–3138 (2011).
  Article CAS PubMed Google Scholar
• Hickman, J. W., Tifrea, D. F. & Harwood, C. S. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels. Proc. Natl Acad. Sci. USA 102, 14422–14427 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Mikkelsen, H., Sivaneson, M. & Filloux, A. Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa. Environ. Microbiol. 13, 1666–1681 (2011).
  Article CAS PubMed Google Scholar
• Sivaneson, M., Mikkelsen, H., Ventre, I., Bordi, C. & Filloux, A. Two-component regulatory systems in Pseudomonas aeruginosa: an intricate network mediating fimbrial and efflux pump gene expression. Mol. Microbiol. 79, 1353–1366 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Borlee, B. R. et al. Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix. Mol. Microbiol. 75, 827–842 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Meissner, A. et al. Pseudomonas aeruginosa cupA-encoded fimbriae expression is regulated by a GGDEF and EAL domain-dependent modulation of the intracellular level of cyclic diguanylate. Environ. Microbiol. 9, 2475–2485 (2007).
  Article CAS PubMed Google Scholar
• Petrova, O. E. & Sauer, K. SagS contributes to the motile-sessile switch and acts in concert with BfiSR to enable Pseudomonas aeruginosa biofilm formation. J Bacteriol. 193, 6614–6628 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Banin, E., Vasil, M. L. & Greenberg, E. P. Iron and Pseudomonas aeruginosa biofilm formation. Proc. Natl Acad. Sci. USA 102, 11076–11081 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Smith, D. J., Lamont, I. L., Anderson, G. J. & Reid, D. W. Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis. Eur. Respir. J. http://dx.doi.org/10.1183/09031936.00124012 (2012).
• Bagge, N. et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob. Agents Chemother. 48, 1175–1187 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hoffman, L. R. et al. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436, 1171–1175 (2005).
  Article CAS PubMed Google Scholar
• Rybtke, M. T. et al. The implication of Pseudomonas aeruginosa biofilms in infections. Inflamm. Allergy Drug Targets. 10, 141–157 (2011).
  Article CAS PubMed Google Scholar
• Taga, M. E. & Bassler, B. L. Chemical communication among bacteria. Proc. Natl Acad. Sci. USA 100, 14549–14554 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Zhu, J. et al. Quorum-sensing regulators control virulence gene expression in Vibrio cholerae. Proc. Natl Acad. Sci. USA 99, 3129–3134 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Gilligan, P. H. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4, 35–51 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Whiteley, M., Lee, K. M. & Greenberg, E. P. Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 96, 13904–13909 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Eberl, L., Molin, S. & Givskov, M. Surface motility of serratia liquefaciens MG1. J. Bacteriol. 181, 1703–1712 (1999).
  CAS PubMed PubMed Central Google Scholar
• Eberl, L. et al. Involvement of _N_-acyl-l-homoserine lactone autoinducers in controlling the multicellular behaviour of Serratia liquefaciens. Mol. Microbiol. 20, 127–136 (1996).
  Article CAS PubMed Google Scholar
• Kohler, T., Curty, L. K., Barja, F., van Delden, C. & Pechere, J. C. Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J. Bacteriol. 182, 5990–5996 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Huber, B. et al. The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 147, 2517–2528 (2001).
  Article CAS PubMed Google Scholar
• Magnuson, R., Solomon, J. & Grossman, A. D. Biochemical and genetic characterization of a competence pheromone from B. subtilis. Cell 77, 207–216 (1994).
  Article CAS PubMed Google Scholar
• Qin, X., Singh, K. V., Weinstock, G. M. & Murray, B. E. Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence. Infect. Immun. 68, 2579–2586 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Hengzhuang, W., Wu, H., Ciofu, O., Song, Z. & Hoiby, N. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 55, 4469–4474 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Bink, A. et al. The non-steroidal anti-inflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms. J. Infect. Dis. 206, 1790–1797 (2012).
  Article CAS PubMed Google Scholar
• Costerton, J. W., Stewart, P. S. & Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322 (1999).
  Article CAS PubMed Google Scholar
• Costerton, J. W. et al. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 41, 435–464 (1987).
  Article CAS PubMed Google Scholar
• Alipour, M., Suntres, Z. E. & Omri, A. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J. Antimicrob. Chemother. 64, 317–325 (2009).
  Article CAS PubMed Google Scholar
• Stewart, P. S. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob. Agents Chemother. 40, 2517–2522 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Herrmann, G. et al. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J. Infect. Dis. 202, 1585–1592 (2010).
  Article CAS PubMed Google Scholar
• Borriello, G. et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob. Agents Chemother. 48, 2659–2664 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Yoon, S. S. et al. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J. Clin. Invest. 116, 436–446 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Borriello, G., Richards, L., Ehrlich, G. D. & Stewart, P. S. Arginine or nitrate enhances antibiotic susceptibility of Pseudomonas aeruginosa in biofilms. Antimicrob. Agents Chemother. 50, 382–384 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Fernandez, L. & Hancock, R. E. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin. Microbiol. Rev. 25, 661–681 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Dibdin, G. H., Assinder, S. J., Nichols, W. W. & Lambert, P. A. Mathematical model of β-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released β-lactamases. J. Antimicrob. Chemother. 38, 757–769 (1996).
  Article CAS PubMed Google Scholar
• Bagge, N. et al. Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 48, 1168–1174 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Gillis, R. J. et al. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 49, 3858–3867 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Chiang, W. C., Pamp, S. J., Nilsson, M., Givskov, M. & Tolker-Nielsen, T. The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms. FEMS Immunol. Med. Microbiol. 65, 245–256 (2012).
  Article CAS PubMed Google Scholar
• Poole, K. Bacterial stress responses as determinants of antimicrobial resistance. J. Antimicrob. Chemother. 67, 2069–2089 (2012).
  Article CAS PubMed Google Scholar
• Kvist, M., Hancock, V. & Klemm, P. Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl. Environ. Microbiol. 74, 7376–7382 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Drenkard, E. & Ausubel, F. M. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416, 740–743 (2002).
  Article CAS PubMed Google Scholar
• Hengzhuang, W. et al. High β-lactamase levels change the pharmacodynamics of β-lactam antibiotics in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 57, 196–204 (2012).
  Article CAS PubMed Google Scholar
• Driffield, K., Miller, K., Bostock, J. M., O'Neill, A. J. & Chopra, I. Increased mutability of Pseudomonas aeruginosa in biofilms. J. Antimicrob. Chemother. 61, 1053–1056 (2008).
  Article CAS PubMed Google Scholar
• Ciofu, O., Riis, B., Pressler, T., Poulsen, H. E. & Høiby, N. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob. Agents Chemother. 49, 2276–2282 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Xu, K. D., Franklin, M. J., Park, C. H., McFeters, G. A. & Stewart, P. S. Gene expression and protein levels of the stationary phase sigma factor, RpoS, in continuously-fed Pseudomonas aeruginosa biofilms. FEMS Microbiol. Lett. 199, 67–71 (2001).
  Article CAS PubMed Google Scholar
• Bjedov, I. et al. Stress-induced mutagenesis in bacteria. Science 300, 1404–1409 (2003).
  Article CAS PubMed Google Scholar
• Lewis, K. Persister cells. Annu. Rev. Microbiol. 64, 357–372 (2010).
  Article CAS PubMed Google Scholar
• Macia, M. D., Perez, J. L., Molin, S. & Oliver, A. Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment. Antimicrob. Agents Chemother. 55, 5230–5237 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Boles, B. R. & Singh, P. K. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc. Natl Acad. Sci. USA 105, 12503–12508 (2008).
  Article PubMed PubMed Central Google Scholar
• Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A. & Collins, J. J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797–810 (2007).
  Article CAS PubMed Google Scholar
• Zhang, Q. et al. Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science 333, 1764–1767 (2011).
  Article CAS PubMed Google Scholar
• Hausner, M. & Wuertz, S. High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl. Environ. Microbiol. 65, 3710–3713 (1999).
  CAS PubMed PubMed Central Google Scholar
• Gristina, A. Biomaterial-centered infection: microbial adhesion versus tissue integration. 1987. Clin. Orthop. Relat. Res. 427, 4–12 (2004).
  Article Google Scholar
• Wahlig, H. & Buchholz, H. W. [Experimental and clinical studies on the release of gentamicin from bone cement]. Chirurg 43, 441–445 (1972).
  CAS PubMed Google Scholar
• Stensballe, J. et al. Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Ann. Intern. Med. 147, 285–293 (2007).
  Article PubMed Google Scholar
• O'Grady, N. P. et al. Guidelines for the prevention of intravascular catheter-related infections. Am. J. Infect. Control 39, S1–34 (2011).
  Article PubMed Google Scholar
• Berra, L. et al. Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial. Intensive Care Med. 34, 1030–1037 (2008).
  Article CAS PubMed Google Scholar
• Kittinger, C. et al. Antimicrobial activity of gentamicin palmitate against high concentrations of Staphylococcus aureus. J. Mater. Sci. Mater. Med. 22, 1447–1453 (2011).
  Article CAS PubMed Google Scholar
• Crnich, C. J. & Maki, D. G. Are antimicrobial-impregnated catheters effective? When does repetition reach the point of exhaustion? Clin. Infect. Dis. 41, 681–685 (2005).
  Article PubMed Google Scholar
• Cho, Y. H. et al. Prophylactic efficacy of a new gentamicin-releasing urethral catheter in short-term catheterized rabbits. BJU Int. 87, 104–109 (2001).
  Article CAS PubMed Google Scholar
• Gaonkar, T. A., Sampath, L. A. & Modak, S. M. Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model. Infect. Control Hosp. Epidemiol. 24, 506–513 (2003).
  Article PubMed Google Scholar
• Johnson, J. R., Kuskowski, M. A. & Wilt, T. J. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann. Intern. Med. 144, 116–126 (2006).
  Article PubMed Google Scholar
• Siddiq, D. M. & Darouiche, R. O. New strategies to prevent catheter-associated urinary tract infections. Nature Rev. Urol. 9, 305–314 (2012).
  Article CAS Google Scholar
• Pickard, R. et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet 380, 1927–1935 (2012).
  Article CAS PubMed Google Scholar
• Vasilev, K., Cook, J. & Griesser, H. J. Antibacterial surfaces for biomedical devices. Expert. Rev. Med. Devices 6, 553–567 (2009).
  Article PubMed Google Scholar
• Bak, J., Begovic, T., Bjarnsholt, T. & Nielsen, A. A UVC device for intra-luminal disinfection of catheters: in vitro tests on soft polymer tubes contaminated with Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli and Candida albicans. Photochem. Photobiol. 87, 1123–1128 (2011).
  Article CAS PubMed Google Scholar
• Polo, A. et al. Effects of photoactivated titanium dioxide nanopowders and coating on planktonic and biofilm growth of Pseudomonas aeruginosa. Photochem. Photobiol. 87, 1387–1394 (2011).
  Article CAS PubMed Google Scholar
• Brady, R. A., O'May, G. A., Leid, J. G., Costerton, J. W. & Shirtliff, M. E. Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment. Infect. Immun. 79, 1797–1803 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Doring, G., Meisner, C. & Stern, M. A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients. Proc. Natl Acad. Sci. USA 104, 11020–11025 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Nilsson, E., Larsson, A., Olesen, H. V., Wejaker, P. E. & Kollberg, H. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients. Pediatr. Pulmonol. 43, 892–899 (2008).
  Article PubMed Google Scholar
• Frederiksen, B., Pressler, T., Hansen, A., Koch, C. & Hoiby, N. Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis. Acta Paediatr. 95, 1070–1074 (2006).
  Article PubMed Google Scholar
• Bjarnsholt, T. et al. Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS ONE 5, e10115 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Alhede, M. et al. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 155, 3500–3508 (2009).
  Article CAS PubMed Google Scholar
• Jensen, P. O. et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 153, 1329–1338 (2007).
  Article CAS PubMed Google Scholar
• van Gennip, M. et al. Interactions between polymorphonuclear leukocytes and Pseudomonas aeruginosa biofilms on silicone implants in vivo. Infect. Immun. 80, 2601–2607 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Jackson, G. G., Dowling, H. F. & Lepper, M. H. Pathogenicity of staphylococci; a comparison of alpha-hemolysin production with the coagulase test and clinical observations of virulence. N. Engl. J. Med. 252, 1020–1025 (1955).
  Article CAS PubMed Google Scholar
• van Gennip, M. et al. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. APMIS 117, 537–546 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bjarnsholt, T. et al. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology 151, 3873–3880 (2005).
  Article CAS PubMed Google Scholar
• Ciofu, O., Bagge, N. & Høiby, N. Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection. APMIS 110, 881–891 (2002).
  Article CAS PubMed Google Scholar
• Ciofu, O. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. APMIS Suppl. 116, 1–47 (2003).
  Google Scholar
• Ciofu, O. et al. Antibodies against Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to beta-lactams. J. Antimicrob. Chemother. 35, 295–304 (1995).
  Article CAS PubMed Google Scholar
• Ciofu, O., Petersen, T. D., Jensen, P. & Hoiby, N. Avidity of anti-P aeruginosa antibodies during chronic infection in patients with cystic fibrosis. Thorax 54, 141–144 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Bjarnsholt, T. & Givskov, M. Quorum sensing inhibitory drugs as next generation antimicrobials: worth the effort? Curr. Infect. Dis. Rep. 10, 22–28 (2008).
  Article PubMed Google Scholar
• Boles, B. R. & Horswill, A. R. _agr_-mediated dispersal of Staphylococcus aureus biofilms. PLoS. Pathog. 4, e1000052 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bjarnsholt, T. et al. In vitro screens for quorum sensing inhibitors and in vivo confirmation of their effect. Nature Protoc. 5, 282–293 (2010).
  Article CAS Google Scholar
• Wu, H. et al. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J. Antimicrob. Chemother. 53, 1054–1061 (2004).
  Article CAS PubMed Google Scholar
• Hentzer, M. et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148, 87–102 (2002).
  Article CAS PubMed Google Scholar
• Skindersoe, M. E. et al. Quorum sensing antagonism from marine organisms. Mar. Biotechnol. 10, 56–63 (2008).
  Article CAS Google Scholar
• Rasmussen, T. B. & Givskov, M. Quorum-sensing inhibitors as anti-pathogenic drugs. Int. J. Med. Microbiol. 296, 149–161 (2006).
  Article CAS PubMed Google Scholar
• Rasmussen, T. B. et al. Identity and effects of quorum sensing inhibitors produced by Penicillum species. Microbiology 151, 1325–1340 (2005).
  Article CAS PubMed Google Scholar
• Rasmussen, T. B. et al. Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J. Bacteriol. 187, 1799–1814 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Camara, M., Williams, P. & Hardman, A. Controlling infection by tuning in and turning down the volume of bacterial small-talk. Lancet Infect. Dis. 2, 667–676 (2002).
  Article CAS PubMed Google Scholar
• Hentzer, M. & Givskov, M. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J. Clin. Invest. 112, 1300–1307 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Jakobsen, T. H. et al. Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob. Agents Chemother. 56, 2314–2325 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Hentzer, M. et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22, 3803–3815 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Christensen, L. D. et al. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model. J. Antimicrob. Chemother. 67, 1198–1206 (2012).
  Article CAS PubMed Google Scholar
• Givskov, M. et al. Eukaryotic interference with homoserine lactone-mediated prokaryotic signalling. J. Bacteriol. 178, 6618–6622 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Ankri, S. & Mirelman, D. Antimicrobial properties of allicin from garlic. Microbes. Infect. 1, 125–129 (1999).
  Article CAS PubMed Google Scholar
• Song, Z. et al. Panax ginseng has anti-infective activity against opportunistic pathogen Pseudomonas aeruginosa by inhibiting quorum sensing, a bacterial communication process critical for establishing infection. Phytomedicine 17, 1040–1046 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, H. et al. Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation. FEMS Immunol. Med. Microbiol. 62, 49–56 (2011).
  Article CAS PubMed Google Scholar
• Choi, K. T. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol. Sin. 29, 1109–1118 (2008).
  Article CAS PubMed Google Scholar
• Skindersoe, M. E. et al. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52, 3648–3663 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kohler, T., Guanella, R., Carlet, J. & van Delden, C. Quorum sensing-dependent virulence during Pseudomonas aeruginosa colonisation and pneumonia in mechanically ventilated patients. Thorax 65, 703–710 (2010).
  Article PubMed Google Scholar
• Patriquin, G. M. et al. Influence of quorum sensing and iron on twitching motility and biofilm formation in Pseudomonas aeruginosa. J. Bacteriol. 190, 662–671 (2008).
  Article CAS PubMed Google Scholar
• Banin, E., Brady, K. M. & Greenberg, E. P. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl. Environ. Microbiol. 72, 2064–2069 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Budzikiewicz, H. Siderophore-antibiotic conjugates used as Trojan horses against Pseudomonas aeruginosa. Curr. Top. Med. Chem. 1, 73–82 (2001).
  Article CAS PubMed Google Scholar
• Ghosh, A. et al. Iron transport-mediated drug delivery using mixed-ligand siderophore-beta-lactam conjugates. Chem. Biol. 3, 1011–1019 (1996).
  Article CAS PubMed Google Scholar
• Reid, D. W. et al. Iron chelation directed against biofilms as an adjunct to conventional antibiotics. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L857–L858 (2009).
  Article CAS PubMed Google Scholar
• Moreau-Marquis, S., O'Toole, G. A. & Stanton, B. A. Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am. J. Respir. Cell. Mol. Biol. 41, 305–313 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Banin, E. et al. The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent. Proc. Natl Acad. Sci. USA 105, 16761–16766 (2008).
  Article PubMed PubMed Central Google Scholar
• Kaneko, Y., Thoendel, M., Olakanmi, O., Britigan, B. E. & Singh, P. K. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J. Clin. Invest. 117, 877–888 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Pichon, C. & Felden, B. Small RNA gene identification and mRNA target predictions in bacteria. Bioinformatics 24, 2807–2813 (2008).
  Article CAS PubMed Google Scholar
• Kint, G., De, C. D., Marchal, K., Vanderleyden, J. & De Keersmaecker, S. C. The small regulatory RNA molecule MicA is involved in Salmonella enterica serovar Typhimurium biofilm formation. BMC Microbiol. 10, 276 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Bordi, C. & de Bentzmann, S. Hacking into bacterial biofilms: a new therapeutic challenge. Ann. Intensive Care 1, 19 (2011).
  Article PubMed PubMed Central Google Scholar
• Achermann, Y., Vogt, M., Leunig, M., Wust, J. & Trampuz, A. Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. J. Clin. Microbiol. 48, 1208–1214 (2010).
  Article PubMed PubMed Central Google Scholar
• Rohacek, M. et al. Bacterial colonization and infection of electrophysiological cardiac devices detected with sonication and swab culture. Circulation 121, 1691–1697 (2010).
  Article PubMed Google Scholar
• Sampedro, M. F. et al. A biofilm approach to detect bacteria on removed spinal implants. Spine 35, 1218–1224 (2010).
  Article PubMed Google Scholar
• Bjerkan, G., Witso, E. & Bergh, K. Sonication is superior to scraping for retrieval of bacteria in biofilm on titanium and steel surfaces in vitro. Acta Orthop. 80, 245–250 (2009).
  Article PubMed PubMed Central Google Scholar
• Kobayashi, N., Bauer, T. W., Tuohy, M. J., Fujishiro, T. & Procop, G. W. Brief ultrasonication improves detection of biofilm-formative bacteria around a metal implant. Clin. Orthop. Relat. Res. 457, 210–213 (2007).
  PubMed Google Scholar
• Young, D., Morton, R. & Bartley, J. Therapeutic ultrasound as treatment for chronic rhinosinusitis: preliminary observations. J. Laryngol. Otol. 124, 495–499 (2010).
  Article CAS PubMed Google Scholar
• Cui, H., Thomee, E., Noble, J. G., Reynard, J. M. & Turney, B. W. Efficacy of the lithotripsy in treating lower pole renal stones. Urolithiasis 41, 231–234 (2013).
  Article PubMed Google Scholar
• Kaplan, J. B. Therapeutic potential of biofilm-dispersing enzymes. Int. J. Artif. Organs 32, 545–554 (2009).
  Article CAS PubMed Google Scholar
• Alkawash, M. A., Soothill, J. S. & Schiller, N. L. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms. APMIS 114, 131–138 (2006).
  Article CAS PubMed Google Scholar
• Sauer, K. et al. Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm. J. Bacteriol. 186, 7312–7326 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Duoll, I. et al. An in vitro study of the rheology of cystic fibrosis sputum following treatment with oligoG alginate oligosaccharide. 23rd Annual North American Cystic Fibrosis Congress [online], (Anaheim, USA; 2011).
  Google Scholar
• Davies, D. G. & Marques, C. N. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J. Bacteriol. 191, 1393–1403 (2009).
  Article CAS PubMed Google Scholar
• Barraud, N. et al. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J. Bacteriol. 188, 7344–7353 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Gjermansen, M., Ragas, P. & Tolker-Nielsen, T. Proteins with GGDEF and EAL domains regulate Pseudomonas putida biofilm formation and dispersal. FEMS Microbiol. Lett. 265, 215–224 (2006).
  Article CAS PubMed Google Scholar
• Ma, Q., Yang, Z., Pu, M., Peti, W. & Wood, T. K. Engineering a novel c-di-GMP-binding protein for biofilm dispersal. Environ. Microbiol. 13, 631–642 (2011).
  Article CAS PubMed Google Scholar
• Antoniani, D., Bocci, P., Maciag, A., Raffaelli, N. & Landini, P. Monitoring of diguanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for high-throughput screening of biofilm inhibitors. Appl. Microbiol. Biotechnol. 85, 1095–1104 (2010).
  Article CAS PubMed Google Scholar
• Heijerman, H., Westerman, E., Conway, S., Touw, D. & Doring, G. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus. J. Cyst. Fibros. 8, 295–315 (2009).
  Article CAS PubMed Google Scholar
• Mermel, L. A. et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49, 1–45 (2009).
  Article CAS PubMed Google Scholar
• Broom, J. et al. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand. J. Infect. Dis. 40, 399–406 (2008).
  Article CAS PubMed Google Scholar
• Barbaric, D., Curtin, J., Pearson, L. & Shaw, P. J. Role of hydrochloric acid in the treatment of central venous catheter infections in children with cancer. Cancer 101, 1866–1872 (2004).
  Article CAS PubMed Google Scholar
• Goss, C. H. et al. Phase 1 pharmacokinetic and safety study of intravenous ganiteTM (Gallium nitrate) in cystic fibrosis. (Abstract 230) Pediatr. Pulmonol. 46 (Suppl. 34), 294 (2011).
  Google Scholar
• Hill, D. et al. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J. Clin. Microbiol. 43, 5085–5090 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Kohler, T., Dumas, J. L. & van Delden, C. Ribosome protection prevents azithromycin-mediated quorum-sensing modulation and stationary-phase killing of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 51, 4243–4248 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Allison, K. R., Brynildsen, M. P. & Collins, J. J. Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr. Opin. Microbiol. 14, 593–598 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Shinde, R. B., Chauhan, N. M., Raut, J. S. & Karuppayil, S. M. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A. Ann. Clin. Microbiol. Antimicrob. 11, 27 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Alem, M. A. & Douglas, L. J. Prostaglandin production during growth of Candida albicans biofilms. J. Med. Microbiol. 54, 1001–1005 (2005).
  Article CAS PubMed Google Scholar
• Alem, M. A. & Douglas, L. J. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob. Agents Chemother. 48, 41–47 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ghalehnoo, Z. R., Rashki, A., Najimi, M. & Dominguez, A. The role of diclofenac sodium in the dimorphic transition in Candida albicans. Microb. Pathog. 48, 110–115 (2010).
  Article CAS PubMed Google Scholar
• Marquez, B. Bacterial efflux systems and efflux pumps inhibitors. Biochimie 87, 1137–1147 (2005).
  Article CAS PubMed Google Scholar
• Liu, Y., Yang, L. & Molin, S. Synergistic activities of an efflux pump inhibitor and iron chelators against Pseudomonas aeruginosa growth and biofilm formation. Antimicrob. Agents Chemother. 54, 3960–3963 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Tirouvanziam, R. et al. High-dose oral _N_-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc. Natl Acad. Sci. USA 103, 4628–4633 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Hughes, K. A., Sutherland, I. W. & Jones, M. V. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144, 3039–3047 (1998).
  Article CAS PubMed Google Scholar
• Webb, J. S. et al. Cell death in Pseudomonas aeruginosa biofilm development. J. Bacteriol. 185, 4585–4592 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Morello, E. et al. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS ONE 6, e16963 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Alemayehu, D. et al. Bacteriophages phiMR299-2 and phiNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio. 3, e00029–e00012 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Merabishvili, M. et al. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE 4, e4944 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Moons, P., Werckx, W., Van Houdt, R., Aertsen, A. & Michiels, C. W. Resistance development of bacterial biofilms against bacteriophage attack. Commun. Agr. Appl. Biol. Sci. 71, 297–300 (2006).
  CAS Google Scholar
• Fu, W. et al. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob. Agents Chemother. 54, 397–404 (2010).
  Article CAS PubMed Google Scholar
• Domenech, M., Garcia, E. & Moscoso, M. In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases. Antimicrob. Agents Chemother. 55, 4144–4148 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Meng, X. et al. Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen Streptococcus suis. Appl. Environ. Microbiol. 77, 8272–8279 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Rolain, J. M., Fancello, L., Desnues, C. & Raoult, D. Bacteriophages as vehicles of the resistome in cystic fibrosis. J. Antimicrob. Chemother. 66, 2444–2447 (2011).
  Article CAS PubMed Google Scholar
• Ojeniyi, B., Birch-Andersen, A., Mansa, B., Rosdahl, V. T. & Hoiby, N. Morphology of Pseudomonas aeruginosa phages from the sputum of cystic fibrosis patients and from the phage typing set. An electron microscopy study. APMIS 99, 925–930 (1991).
  Article CAS PubMed Google Scholar
• Willner, D. et al. Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. PLoS ONE 4, e7370 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Parracho, H. M., Burrowes, B. H., Enright, M. C., McConville, M. L. & Harper, D. R. The role of regulated clinical trials in the development of bacteriophage therapeutics. J. Mol. Genet. Med. 6, 279–286 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wright, A., Hawkins, C. H., Anggard, E. E. & Harper, D. R. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin. Otolaryngol. 34, 349–357 (2009).
  Article CAS PubMed Google Scholar
• Brussow, H. Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining? MBio 3, e00061–e00112 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Hoffmann, N. et al. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary growth phase killing of P. aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr −/− mice. Antimicrob. Agents Chemother. 51, 3677–3687 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Song, Z. et al. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection. Antimicrob. Agents Chemother. 49, 3868–3874 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Brinch, K. S. et al. Plectasin shows intracellular activity against Staphylococcus aureus in human THP-1 monocytes and in a mouse peritonitis model. Antimicrob. Agents Chemother. 53, 4801–4808 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nature Rev. Drug Discov. 6, 29–40 (2007).
  Article CAS Google Scholar
• Hassett, D. J. et al. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv. Drug Deliv. Rev. 54, 1425–1443 (2002).
  Article CAS PubMed Google Scholar
• Lu, C. D., Winteler, H., Abdelal, A. & Haas, D. The ArgR regulatory protein, a helper to the anaerobic regulator ANR during transcriptional activation of the arcD promoter in Pseudomonas aeruginosa. J. Bacteriol. 181, 2459–2464 (1999).
  CAS PubMed PubMed Central Google Scholar
• Stover, C. K. et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406, 959–964 (2000).
  Article CAS PubMed Google Scholar
• O'Toole, G. A. & Kolter, R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28, 449–461 (1998).
  Article CAS PubMed Google Scholar
• Ceri, H. et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37, 1771–1776 (1999).
  CAS PubMed PubMed Central Google Scholar
• Anderl, J. N., Franklin, M. J. & Stewart, P. S. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 44, 1818–1824 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Goeres, D. M. et al. A method for growing a biofilm under low shear at the air-liquid interface using the drip flow biofilm reactor. Nature Protoc. 4, 783–788 (2009).
  Article CAS Google Scholar
• Zelver, N. et al. Measuring antimicrobial effects on biofilm bacteria: from laboratory to field. Methods Enzymol. 310, 608–628 (1999).
  Article CAS PubMed Google Scholar
• Werthen, M. et al. An in vitro model of bacterial infections in wounds and other soft tissues. APMIS 118, 156–164 (2010).
  Article PubMed Google Scholar
• Merritt, J. H., Kadouri, D. E. & O'Toole, G. A. Growing and analyzing static biofilms. Curr. Protoc. Microbiol. http://dx.doi.org/10.1002/9780471729259.mc01b01s00 (2005).
• Kirketerp-Moller, K. et al. Distribution, organization, and ecology of bacteria in chronic wounds. J. Clin. Microbiol. 46, 2717–2722 (2008).
  Article PubMed PubMed Central Google Scholar
• Bjarnsholt, T., Tolker-Nielsen, T., Hoiby, N. & Givskov, M. Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control. Expert. Rev. Mol. Med. 12, e11 (2010).
  Article CAS PubMed Google Scholar
• Tanaka, G. et al. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents: beta-lactams and fluoroquinolones. Chemotherapy 45, 28–36 (1999).
  Article CAS PubMed Google Scholar
• Vrany, J. D., Stewart, P. S. & Suci, P. A. Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa biofilms displaying rapid-transport characteristics. Antimicrob. Agents Chemother. 41, 1352–1358 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, L. & Mah, T. F. Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J. Bacteriol. 190, 4447–4452 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Anwar, H., Strap, J. L. & Costerton, J. W. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob. Agents Chemother. 36, 1347–1351 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Mulcahy, H., Charron-Mazenod, L. & Lewenza, S. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS. Pathog. 4, e1000213 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hocquet, D. et al. MexXY–OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 47, 1371–1375 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Mah, T. F. et al. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426, 306–310 (2003).
  Article CAS PubMed Google Scholar